StreetInsider.com News Articles

Form 15-12G BIOLIFE SOLUTIONS INC

Fri, 16 Oct 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20261016/27197894.html

Form EFFECT BIOLIFE SOLUTIONS INC

Tue, 13 Oct 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20261013/27176249.html

Form EFFECT BIOLIFE SOLUTIONS INC

Tue, 13 Oct 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20261013/27176257.html

Form 4 BIOLIFE SOLUTIONS INC For: Oct 06 Filed by: Wichterman Troy

Thu, 08 Oct 2026 22:00:00 -0400

si-local-file:///var/storage/secattach/20261008/27168110.html

Form 4 BIOLIFE SOLUTIONS INC For: Oct 06 Filed by: GOSWAMI JOYDEEP

Thu, 08 Oct 2026 22:00:00 -0400

si-local-file:///var/storage/secattach/20261008/27168111.html

Form 4 BIOLIFE SOLUTIONS INC For: Oct 06 Filed by: DE GREEF RODERICK

Thu, 08 Oct 2026 21:59:00 -0400

si-local-file:///var/storage/secattach/20261008/27168105.html

Form 4 BIOLIFE SOLUTIONS INC For: Oct 06 Filed by: Coste Catherine

Thu, 08 Oct 2026 21:59:00 -0400

si-local-file:///var/storage/secattach/20261008/27168106.html

Form 4 BIOLIFE SOLUTIONS INC For: Oct 06 Filed by: DuRoss Amy

Thu, 08 Oct 2026 21:59:00 -0400

si-local-file:///var/storage/secattach/20261008/27168107.html

Form 4 BIOLIFE SOLUTIONS INC For: Oct 06 Filed by: Ellingson Rachel

Thu, 08 Oct 2026 21:59:00 -0400

si-local-file:///var/storage/secattach/20261008/27168108.html

Form 4 BIOLIFE SOLUTIONS INC For: Oct 06 Filed by: MOORE TIMOTHY L.

Thu, 08 Oct 2026 21:58:00 -0400

si-local-file:///var/storage/secattach/20261008/27168102.html

Form 4 BIOLIFE SOLUTIONS INC For: Oct 06 Filed by: Mathew Aby J.

Thu, 08 Oct 2026 21:58:00 -0400

si-local-file:///var/storage/secattach/20261008/27168103.html

Form 4 BIOLIFE SOLUTIONS INC For: Oct 06 Filed by: Hunt Anthony

Thu, 08 Oct 2026 21:58:00 -0400

si-local-file:///var/storage/secattach/20261008/27168104.html

Form 4 BIOLIFE SOLUTIONS INC For: Oct 06 Filed by: Berard Todd

Thu, 08 Oct 2026 21:56:00 -0400

si-local-file:///var/storage/secattach/20261008/27168100.html

Form 4 BIOLIFE SOLUTIONS INC For: Oct 06 Filed by: Werner Sean

Thu, 08 Oct 2026 21:55:00 -0400

si-local-file:///var/storage/secattach/20261008/27168098.html

Form S-8 POS BIOLIFE SOLUTIONS INC

Tue, 06 Oct 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20261006/27155600.html

Form S-8 POS BIOLIFE SOLUTIONS INC

Tue, 06 Oct 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20261006/27155533.html

Form S-8 POS BIOLIFE SOLUTIONS INC

Tue, 06 Oct 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20261006/27155486.html

Form POS AM BIOLIFE SOLUTIONS INC

Tue, 06 Oct 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20261006/27155374.html

Form POS AM BIOLIFE SOLUTIONS INC

Tue, 06 Oct 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20261006/27155346.html

Form 25-NSE BIOLIFE SOLUTIONS INC Filed by: Nasdaq Stock Market LLC

Tue, 06 Oct 2026 09:38:00 -0400

si-local-file:///var/storage/secattach/20261006/27153420.html

Form 8-K BIOLIFE SOLUTIONS INC For: Oct 06

Tue, 06 Oct 2026 09:11:00 -0400

si-local-file:///var/storage/secattach/20261006/27153240.html

Repligen completes acquisition of BioLife Solutions for cash and stock

Tue, 06 Oct 2026 09:05:22 -0400

Repligen Corporation (NASDAQ: RGEN) announced it has completed its acquisition of BioLife Solutions, Inc. (NASDAQ: BLFS), a developer and supplier of cell processing tools and services for the cell and gene therapy market, according to a press release dated Oct. 6, 2026.

Under the terms of the transaction, BioLife stockholders received $11.25 per share in cash and 0.1442 shares of Repligen common stock, with cash paid in lieu of any fractional shares.

BioLife's biopreservation media portfolio, led by its CryoStor product, supports 18 commercially approved therapies and the majority of U.S. commercially sponsored cell-based therapy trials.

"We are excited to welcome BioLife team

Repligen completes acquisition of BioLife Solutions for cash and stock

Tue, 06 Oct 2026 09:05:22 -0400

Under the terms of the transaction, BioLife stockholders received $11.25 per share in cash and 0.1442 shares of Repligen common stock, with cash paid in lieu of any fractional shares.

BioLife's biopreservation media portfolio, led by its CryoStor product, supports 18 commercially approved therapies and the majority of U.S. commercially sponsored cell-based therapy trials.

"We are excited to welcome BioLife team

Repligen Completes Acquisition of BioLife Solutions

Tue, 06 Oct 2026 09:05:00 -0400

WALTHAM, Mass., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN, “Repligen”, or the “Company”), a life sciences company focused on bioprocessing technology leadership, today announced it has completed the previously announced acquisition of BioLife Solutions, Inc. (NASDAQ: BLFS, “BioLife”), a leading developer and supplier of cell processing tools and services for the cell and gene therapy market.

“We are excited to welcome BioLife team members to Repligen,” said Olivier Loeillot, President and Chief Executive Officer of Repligen. “BioLife’s highly-differentiated portfolio of products expands our presence in the rapidly growing cell therapy market, adding a deeply embedded, high-margin

Repligen Completes Acquisition of BioLife Solutions

Tue, 06 Oct 2026 09:05:00 -0400